Semaglutide and Ozempic-like drugs may improve kidney disease outcomes
Semaglutide—a drug commonly used for weight-loss—also slows kidney disease in type 2 diabetics, improving function and survival. Benefits likely stem from metabolic effects, though exact mechanisms need further research.